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Background/Aims: To determine whether early diagnosis is beneficial for func-
tional status of various disease durations in rheumatoid arthritis (RA) patients.
Methods: A total of 4,540 RA patients were enrolled as part of the Korean Obser-
vational Study Network for Arthritis (KORONA). We defined early diagnosis as 
a lag time between symptom onset and RA diagnosis of ≤ 12 months, whereas 
patients with a longer lag time comprised the delayed diagnosis group. Demo-
graphic characteristics and outcomes were compared between early and delayed 
diagnosis groups. Logistic regression analyses were performed to identify the im-
pact of early diagnosis on the development of functional disability in RA patients. 
Results: A total of 2,597 patients (57.2%) were included in the early diagnosis 
group. The average Health Assessment Questionnaire-Disability Index (HAQ-DI) 
score was higher in the delayed diagnosis group (0.64 ± 0.63 vs. 0.70 ± 0.66, p < 0.01), 
and the proportion of patients with no functional disability (HAQ = 0) was higher 
in the early diagnosis group (22.9% vs. 20.0%, p = 0.02). In multivariable analyses, 
early diagnosis was independently associated with no functional disability (odds 
ratio [OR], 1.19; 95% confidence interval [CI], 1.01 to 1.40). In a subgroup analysis 
according to disease duration, early diagnosis was associated with no functional 
disability in patients with disease duration < 5 years (OR, 1.37; 95% CI, 1.09 to 1.72) 
but not in patients with longer disease duration (for 5 to 10 years: OR, 1.07; 95% 
CI, 0.75 to 1.52; for ≥ 10 years: OR, 0.92; 95% CI, 0.65 to 1.28).
Conclusions: Early diagnosis is associated with no functional disability, especial-
ly in patients with shorter disease duration. 
Keywords: Early diagnosis; Disability; Arthritis, rheumatoid; Health assessment 
questionnaires
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INTRODUCTION
During the past decade, early diagnosis and treatment of 
rheumatoid arthritis (RA) have been emphasized because 
a window of opportunity is believed to exist in early RA 
during which the disease is more responsive to treat-
ment [1-3]. Previous studies revealed that early diagno-
sis and treatment prevent radiologic progression of RA 
and predict a greater rate of remission than does delayed 
treatment [4-6]. A meta-analysis of the literature showed 
that long-term progression of radiographic damage was 
significantly less frequent in patients treated with ear-
ly disease-modifying anti-rheumatic drugs (DMARDs) 
than in patients receiving delayed treatment [6]. In addi-
tion, many studies have revealed that early intervention 
with DMARDs leads to a greater rate of remission than 
delayed intervention [7,8]. 
Although functional outcome is as important as dis-
ease activity and radiologic progression, only a few stud-
ies have investigated the influence of early treatment on 
functional outcome [8-11]. Moreover, these studies fo-
cused on patients with relatively short disease duration, 
between 1 to 3 years, and the effect of early diagnosis and 
treatment on functional outcome according to disease 
duration is not clear.
In this study, the aim was to determine whether early 
diagnosis and treatment have benefits with respect to 
functional status with various disease durations in pa-
tients with RA. 
METHODS 
Study population
All RA patients aged 18 or older who satisfied the 1987 
American College of Rheumatology criteria for RA [12] 
and who planned to have their blood drawn for routine 
evaluation were asked to provide informed consent and 
more than 95% of patients who were requested consent-
ed to participate in Korean Observational Study Net-
work For Arthritis (KORONA) cohort [13]. A total of 5,376 
patients agreed to participate in KORONA which is one 
of the largest nationwide RA cohorts in Korea. Patients 
were recruited between September 2009 and December 
2011. 
We defined the date of symptom onset as the date on 
which the patient first recognized joint pain or swell-
ing, and the date of diagnosis as the date on which the 
patient was diagnosed with RA and received treatment 
based on common clinical practice by a physician. We 
defined early diagnosis as a lag time between symptom 
onset and an RA diagnosis of 12 months or shorter [4]. 
Patients who had a longer lag time were classified as the 
delayed diagnosis group. All patients provided informed 
consent under a protocol approved by the Institutional 
Review Board of each site.
Functional disability and associated factors
Functional disability was measured at enrollment with 
the Health Assessment Questionnaire-Disability Index 
(HAQ-DI) validated for use in Korean patients [14]. The 
range of HAQ-DI scores is between 0 and 3, where 0 
represents no disability and 3 indicates complete dis-
ability. In our study, we defined no functional disability 
as HAQ-DI = 0, since HAQ-DI in our data was strongly 
skewed to 0 and clinically no disability was the goal of 
RA treatment (Fig. 1).
In order to find the factors associated with no func-
tional disability (HAQ-DI = 0), the demographic char-
acteristics and clinical information were collected by 
detailed interviews and medical records, and disease 
activity was obtained by rheumatologists or well-trained 
health professionals at enrollment [15-17]. Since there 
were many patients with longer disease durations, to re-
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Figure 1. Distribution of Health Assessment Questionnaire-
Disability Index (HAQ-DI) in this study.
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duce the recall bias about remote information including 
date of symptom onset and RA diagnosis, well-trained 
interviewer circumstantially asked patients about this 
information, accompanied by chart review in available 
patients.
Information on bone erosion at diagnosis was collect-
ed by rheumatologists or radiologists by determining 
whether bone erosion was present on hand and wrist 
radiographs using the radiographic image or descrip-
tion of bone erosion on medical chart of patients when 
they were diagnosed. Comorbidities were composed of 
prevalent diseases among RA patients including cardio-
vascular disease, hypertension, gastrointestinal disease, 
hepatitis, diabetes mellitus, thyroid disease, pulmonary 
disease, and malignancy.
Statistical analysis
In addition to demographic characteristics, clinical in-
formation, and disease activity, we compared the HAQ-
DI score and the proportion of patients with no func-
tional disability between early and delayed diagnosis 
groups, using the chi-square test and Student t test. 
Multivariable logistic regression analysis was performed 
to identify the impact of early diagnosis on no func-
tional disability, adjusting for variables such as age, sex, 
disease duration, education, absence of bone erosion, 
rheumatoid factor (RF) positivity, hemoglobin, disease 
activity score employing 28 joint-erythrocyte sedimen-
tation rate (DAS28-ESR) and no comorbidity that were 
known to be associated with functional disability in pre-
vious studies [15-17] or significant in the crude analysis. 
The significance level was set at p < 0.05.
Three separate logistic regression models were per-
formed, according to disease duration, to analyze the 
impact of early diagnosis on functional disability of dis-
ease course. The disease durations tested, which defined 
as the duration between date of diagnosis and enroll-
ment, were less than 5, 5 to 10, and ≥ 10 years. For three 
separate logistic regression models, p value adjusted for 
multiple comparisons (p < 0.0167 corrected for three 
analysis) by the Bonferroni method was considered to 
be statistically significant. Statistical analyses were per-
formed using SAS software version 9.2 (SAS, Cary, NC, 
USA). 
RESULTS
Demographic and clinical features
A total of 2,597 patients (57.2%) were included in the early 
diagnosis group and 1,943 patients (42.8%) in the delayed 
diagnosis group. The demographic and clinical charac-
teristics of the patients are listed in Table 1.
The mean delay before diagnosis was 3.5 ± 3.7 months 
in the early diagnosis group and 48.7 ± 62.8 months in 
the delayed diagnosis group. The early diagnosis group 
was younger (52.8 ± 12.1 years vs. 54.5 ± 12.2 years, p < 0.01) 
and its mean disease duration was longer than that of the 
delayed diagnosis group (8.3 ± 7.7 years vs. 7.5 ± 7.3 years, p 
< 0.01). The early diagnosis group also had a higher edu-
cational level than the delayed diagnosis group (59.5% vs. 
53.8% with high school or higher, p < 0.01). 
In terms of functional disability, the average HAQ-DI 
score was higher in the delayed diagnosis group (0.64 
± 0.63 vs. 0.70 ± 0.66, p < 0.01), the mean difference be-
tween two groups was 0.06, standard error 0.02, and 
95% confidence interval (CI) was 0.021 and 0.097. The 
proportion of patients with no functional disability was 
higher in the early diagnosis group (22.9% vs. 20.0%, p = 
0.02), especially in those with disease duration less than 
5 years (29.7% vs. 23.8%, p < 0.01) (Fig. 2).
Impact of early diagnosis on no functional disability
Early diagnosis was associated with no functional dis-
ability (odds ratio [OR], 1.19; 95% CI, 1.03 to 1.37) in crude 
analysis. In addition, several of the variables listed in 
Table 2 were also significantly associated with no func-
tional disability.
After adjusting for variables that were significant in 
crude analysis, early diagnosis (OR, 1.19; 95% CI, 1.01 to 
1.40) remained associated with no functional disability. 
In addition, male gender (OR, 2.88; 95% CI, 2.29 to 3.63), 
disease duration less than 5 years (OR, 1.42; 95% CI, 1.16 
to 1.75), higher level of education (OR, 1.70; 95% CI, 1.39 
to 2.07), absence of bone erosion at diagnosis (OR, 1.42; 
95% CI, 1.20 to 1.68), RF positivity (OR, 1.49; 95% CI, 1.13 
to 1.98), and lack of comorbidity (OR, 1.30; 95% CI, 1.09 to 
1.54) were associated with no functional disability. The 
age (OR, 0.98; 95% CI, 0.97 to 0.99) and DAS28-ESR (OR, 
0.45; 95% CI, 0.42 to 0.49) were negatively associated with 
no functional disability. 
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Impact of early diagnosis on no functional disability 
according to disease duration
We also performed a subgroup analysis to analyze the 
influence of early diagnosis on no functional disability 
according to disease duration (Table 3). Early diagnosis 
was associated with no functional disability in patients 
with disease duration less than 5 years (OR, 1.37; 95% CI, 
1.09 to 1.72) but not in patients with longer disease dura-
tion (for 5 to 10 years: OR, 1.07; 95% CI, 0.75 to 1.52; for ≥ 
10 years: OR, 0.92; 95% CI, 0.65 to 1.28).
In addition, no functional disability was affected by 
several variables along with the disease course. RF pos-
itivity (OR, 1.66; 95% CI, 1.16 to 2.38) was associated with 
no functional disability only where disease duration was 
less than 5 years. On the other hands, absence of bone 
erosion at diagnosis (OR, 1.73; 95% CI, 1.23 to 2.43 for ≥ 10 
Table 1. Demographic and clinical characteristics of rheumatoid arthritis patients at enrollment
Characteristic Number
Early diagnosis group
(n = 2,597)
Delayed diagnosis group 
(n = 1,943)
p value
Age, yr 4,540 52.8 ± 12.1 54.5 ± 12.2 < 0.01
Male sex 4,540 365 (14.1) 303 (15.6) 0.16
Disease duration, yr 4,540 0.02
< 5 1,129 (43.5) 923 (47.5)
5 ≤ and < 10 590 (22.7) 423 (21.8)
≥ 10 878 (33.8) 597 (30.7)
Education 4,520 < 0.01
Middle school or less 1,047 (40.5) 895 (46.2)
High school or more 1,537 (59.5) 1,041 (53.8)
RF positivity 4,540 2,357 (90.8) 1,743 (89.7) 0.26
Anti-CCP positivity 3,522 1,726 (84.7) 1,253 (84.4) 0.81
Hemoglobin, g/dL 4,533 12.5 ± 1.4 12.5 ± 1.4 0.98
ESR, mm/hr 4,540 29.1 ± 23.8 29.4 ± 24.4 0.68
CRP, mm/dL 4,450 0.8 ± 1.2 0.8 ± 1.3 0.52
Extra-articular manifestations
Rheumatoid nodules 4,539 99 (3.8) 74 (3.8) 1.00
Interstitial lung disease 4,540 20 (0.8) 21 (1.1) 0.35
Bone erosion at diagnosis 4,539 1,411 (54.3) 1,090 (56.2) 0.21
Comorbidities positivity 4,540 1,469 (56.6) 1,090 (56.1) 0.78
DAS28-ESR 4,540 3.7 ± 1.3 3.7 ± 1.4 0.33
HAQ-DI score 4,540 0.64 ± 0.63 0.70 ± 0.66 < 0.01
HAQ-DI = 0 4,540 594 (22.9) 388 (20.0) 0.02
Medications 4,540
MTX 2,157 (83.1) 1,620 (83.4) 0.81
Weekly dose, mg/wk 3,769 12.6 ± 2.9 12.6 ± 3.0 0.99
Corticosteroids 1,947 (75.0) 1,383 (71.2) < 0.01
Daily dose, mg/day 3,260 4.5 ± 2.6 4.3 ± 2.4 0.12
Biologic agents 168 (6.5) 118 (6.1) 0.63
Values are presented as mean ± SD or number (%). 
RF, rheumatoid factor; CCP, cyclic citrullinated protein; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; 
DAS28-ESR, disease activity score employing 28 joint-erythrocyte sedimentation rate; HAQ-DI, Health Assessment Question-
naire-Disability Index; MTX, methotrexate.
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years) was associated with no functional disability where 
disease duration exceeded 10 years. Male gender (for < 5 
years: OR, 2.69; 95% CI, 1.96 to 3.70; for 5 to 10 years: OR, 
3.29; 95% CI, 2.03 to 5.32; for ≥ 10 years: OR, 3.00; 95% CI, 
1.86 to 4.85) and DAS28-ESR (for < 5 years: OR, 0.46; 95% 
CI, 0.41 to 0.51; for 5 to 10 years: OR, 0.41; 95% CI, 0.34 to 
0.48; for ≥ 10 years: OR, 0.47; 95% CI, 0.40 to 0.55) were 
consistently associated with no functional disability ir-
respective of disease duration. 
DISCUSSION
In this study, the early diagnosis group showed lower 
HAQ-DI score, and a higher proportion of patients with 
no functional disability compared with delayed diag-
nosis group, though the differences were not large. We 
found that early diagnosis was independently associated 
with no functional disability after adjusting for various 
factors. In particular, early diagnosis was associated with 
no functional disability in patients with disease duration 
of less than 5 years, whereas no benefit of early diagno-
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Figure 2. Proportion of patients with no functional dis-
ability (Health Assessment Questionnaire-Disability Index 
[HAQ-DI] score = 0) in each group according to disease du-
ration. ap < 0.05, chi-square test.
Table 2. Associated factors for no functional disability (HAQ-DI = 0)
Factor Crude OR (95% CI) Multivariable OR (95% CI)
Age, yr 0.97 (0.96–0.97)a 0.98 (0.97–0.99)a
Male sex 3.42 (2.87–4.07)a 2.88 (2.29–3.63)a
Early diagnosis 1.19 (1.03–1.37)a 1.19 (1.01–1.40)a
Disease duration, yr
< 5 2.34 (1.96–2.79)a 1.42 (1.16–1.75)a
≥ 5 and < 10 1.80 (1.46–2.22)a 1.25 (0.99–1.59)
≥ 10 1 1
Education
Middle school or less 1 1
High school or more 2.50 (2.14–2.93)a 1.70 (1.39–2.07)a
Absence of bone erosion at diagnosis 1.94 (1.68–2.24)a 1.42 (1.20–1.68)a
RF positivity 1.07 (0.84–1.36) 1.49 (1.13–1.98)a
Hemoglobin 1.36 (1.28–1.43)a 0.95 (0.89–1.02)
DAS28-ESR 0.43 (0.40–0.46)a 0.45 (0.42–0.49)a
No comorbidity 1.62 (1.41–1.87)a 1.30 (1.09–1.54)a
Multivariable OR was adjusted for age, sex, disease duration, education, absence of bone erosion, RF positivity, hemoglobin, 
DAS28-ESR, and no comorbidity.
HAQ-DI, Health Assessment Questionnaire-Disability Index; OR, odds ratio; CI, confidence interval; RF, rheumatoid factor; 
DAS28-ESR, disease activity score employing 28 joint-erythrocyte sedimentation rate.
ap < 0.05.
743
Kim D, et al. Early diagnosis and disability in RA
www.kjim.org https://doi.org/10.3904/kjim.2015.364
sis was observed in patients with disease duration more 
than 5 years. However, male gender and lower disease 
activity were consistently associated with no functional 
disability. In addition, absence of bone erosion at diag-
nosis was an independent factor for no functional dis-
ability where disease duration was longer than 10 years. 
There have been several studies which assessed fac-
tors affecting functional outcome in RA patients [15-17]. 
They reported that several variables including age, gen-
der, education, disease duration, disease activity, radio-
graphic progression, and comorbidity were associated 
with functional disability; these results were comparable 
with our study. On the other hand, in our study, positive 
RF showed results opposite to those of previous study 
that reported positive RF was a predictor of worse func-
tional disability [15]. Since positive RF is one of the crite-
ria in RA classification [12,18], patients with positive RF 
tend to be diagnosed earlier and have greater possibility 
of receiving intensive treatment. Therefore, we assumed 
that positive RF could be associated with no functional 
disability when adjusting for variables including early 
diagnosis. However, further study for RF and functional 
status is needed to lead a conclusive result.
In our study, the mean difference of HAQ-DI score 
between early and delayed diagnosis group was 0.06; 
it is a relatively small difference, and does not exceed 
the minimally important difference (MID) for HAQ-
DI from previous studies [19-23]. Considering that the 
mean HAQ-DI scores from previous studies were up to 
twice than ours, the MID of our study would be expect-
ed to be smaller than theirs. However, this difference of 
0.06 might be clinically insignificant and thus addition-
al study of MID in patients with similar baseline HAQ-
DI is required.
Concerning the early diagnosis, a few previous studies 
have investigated the impact of early diagnosis on func-
tional disability (Table 4) [8-11]. Two reported better out-
comes for patients diagnosed early [8,10], whereas others 
found similar outcomes between the early diagnosis and 
delayed diagnosis groups [9,11]. The patients examined 
in those studies were early RA patients who had never 
received DMARDs, and the numbers of patients inves-
tigated ranged from 40 to 608. Two of these studies de-
fined early diagnosis as a delay of less than 3 months 
from symptoms to diagnosis of RA [8,10]. The others 
classified patients into an early and a delayed treatment 
group according to the time between first visit and refer-
ral or referral and the start DMARDs [9,11]. The former 
pair of studies noted that HAQ scores improved more in 
the early diagnosis group and more patients in the early 
Table 3. Associated factors for no functional disability (HAQ-DI = 0) according to disease duration
Factor
Disease duration, yr, OR (95% CI)
< 5 (n = 2,052) 5 ≤ and < 10 (n = 1,013) ≥ 10 (n = 1,475)
Age 0.98 (0.97–0.99)a 0.98 (0.97–1.00) 0.98 (0.96–0.99)a
Male sex 2.69 (1.96–3.70)a 3.29 (2.03–5.32)a 3.00 (1.86–4.85)a
Early diagnosis 1.37 (1.09–1.72)a 1.07 (0.75–1.52) 0.92 (0.65–1.28)
Education
Middle school or less 1 1 1
High school or more 1.93 (1.45–2.57)a 1.44 (0.94–2.21) 1.50 (1.02–2.21)
Absence of bone erosion at diagnosis 1.25 (0.99–1.58) 1.50 (1.06–2.11) 1.73 (1.23–2.43)a
RF positivity 1.66 (1.16–2.38)a 1.68 (0.84–3.39) 0.97 (0.54–1.74)
Hemoglobin 0.94 (0.85–1.03) 0.97 (0.85–1.11) 0.99 (0.86–1.13)
DAS28-ESR 0.46 (0.41–0.51)a 0.41 (0.34–0.48)a 0.47 (0.40–0.55)a
No comorbidity 1.23 (0.98–1.56) 1.40 (0.97–2.01) 1.36 (0.97–1.92)
Multivariable OR was adjusted for age, sex, education, absence of bone erosion, RF positivity, hemoglobin, DAS28-ESR, and no 
comorbidity.
HAQ-DI, Health Assessment Questionnaire-Disability Index; OR, odds ratio; CI, confidence interval; RF, rheumatoid factor; 
DAS28-ESR, disease activity score employing 28 joint-erythrocyte sedimentation rate.
ap < 0.0167 (Bonferroni adjustment).
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group achieved an HAQ score below 0.5 or 1.0 [8,10]. On 
the other hand, the latter pair of studies found only a 
modest improvement in HAQ scores, which, moreover, 
was similar in the two groups [9,11]. 
Our study differs in several respects from these pre-
vious studies. First, we used a large nationwide observa-
tional cohort that may better represent the actual clini-
cal situation. Second, we included patients at all stages of 
the disease in order to reveal the effects of early diagno-
sis and treatment on functional disability with various 
disease durations. Third, the earlier studies examined 
the unadjusted effects on functional disability caused 
by early or delayed diagnosis; however, we adjusted for 
significant factors affecting HAQ-DI scores, namely age, 
gender, disease duration, level of education, initial joint 
damage, RF positivity, hemoglobin, disease activity, and 
comorbidity to identify the independent effect of early 
diagnosis on functional disability. 
Interestingly, early diagnosis had an important influ-
ence on no functional disability over all disease dura-
tions, but in a subgroup analysis, the effect was only 
statistically significant for durations of less than 5 years. 
These results might be interpreted differently as a ne-
glectable small effect of early diagnosis on functional 
disability, especially in disease duration longer than 5 
years.
However, we can suggest three possible explanations 
for why the effect was restricted to patients with disease 
that had been present for less than 5 years. First, since 
age is a powerful determinant of functional disabil-
ity [24], the impact of early diagnosis could be reduced 
in patients with longer disease duration because they 
tend to be older than those with shorter disease dura-
tion. Second, because we used a cross-sectional design, 
the common clinical practice of initial treatment was 
not identical according to the periods; the patients with 
long disease duration may have had less chance to re-
ceive aggressive treatments such as anti-tumor necrosis 
factor agents early in the course of their disease. Further 
study using detailed information about initial treatment 
could lead to more reliable results about early diagnosis 
and functional disability. Moreover, it was not possible 
to use time dependent variables in this analysis which 
can draw more reliable result about association of early 
diagnosis and functional disability along time, since 
this study was a cross-sectional study using enrollment Ta
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data. We think we can draw a conclusive result when 
we analyze repetitive data using follow-up outcomes 
in future study using the prospective KORONA cohort. 
Third, since many of our patients had long disease du-
rations, there may have been recall bias for symptom 
onset and date of diagnosis. The distinction between 
early and delayed diagnosis may therefore be more reli-
able in the case of patients with recent disease onset, but 
less reliable in the case of patients with disease of longer 
duration because of recall bias. This could have reduced 
the differences of functional disability between the early 
and delayed diagnosis groups among the patients with 
longer disease duration. 
Despite the above limitations, our data show that early 
diagnosis is associated with no functional disability as 
well as other variables. A prospective cohort study of pa-
tients with relatively short disease durations of less than 
5 years would allow the confirmation of the impact of 
early diagnosis on functional disability in the cases of 
longer disease durations. 
In conclusion, early diagnosis was associated with no 
functional disability, especially in patients with shorter 
disease duration. On the other hand, absence of bone 
erosion at diagnosis was an independent factor for no 
functional disability where disease duration was longer 
than 10 years. Male gender and lower disease activity 
were consistently associated with no functional disabil-
ity. Additional studies will be required to confirm these 
findings in the cases of longer disease durations. In ad-
dition, the difference of HAQ-DI score between early 
and delayed diagnosis group in this study was small; 
therefore, further study using patient population with 
various HAQ-DI distribution is needed to draw conclu-
sive results.
KEY MESSAGE 
1. Early diagnosis was associated with no func-
tional disability, especially in patients with 
shorter disease duration.
2. Absence of bone erosion at diagnosis was an 
independent factor for no functional disability 
where disease duration was longer than 10 years.
3. Male gender and lower disease activity were 
consistently associated with no functional dis-
ability.
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in future study using the prospective KORONA cohort. 
Third, since many of our patients had long disease du-
rations, there may have been recall bias for symptom 
onset and date of diagnosis. The distinction between 
early and delayed diagnosis may therefore be more reli-
able in the case of patients with recent disease onset, but 
less reliable in the case of patients with disease of longer 
duration because of recall bias. This could have reduced 
the differences of functional disability between the early 
and delayed diagnosis groups among the patients with 
longer disease duration. 
Despite the above limitations, our data show that early 
diagnosis is associated with no functional disability as 
well as other variables. A prospective cohort study of pa-
tients with relatively short disease durations of less than 
5 years would allow the confirmation of the impact of 
early diagnosis on functional disability in the cases of 
longer disease durations. 
In conclusion, early diagnosis was associated with no 
functional disability, especially in patients with shorter 
disease duration. On the other hand, absence of bone 
erosion at diagnosis was an independent factor for no 
functional disability where disease duration was longer 
than 10 years. Male gender and lower disease activity 
were consistently associated with no functional disabil-
ity. Additional studies will be required to confirm these 
findings in the cases of longer disease durations. In ad-
dition, the difference of HAQ-DI score between early 
and delayed diagnosis group in this study was small; 
therefore, further study using patient population with 
various HAQ-DI distribution is needed to draw conclu-
sive results.
KEY MESSAGE 
1. Early diagnosis was associated with no func-
tional disability, especially in patients with 
shorter disease duration.
2. Absence of bone erosion at diagnosis was an 
independent factor for no functional disability 
where disease duration was longer than 10 years.
3. Male gender and lower disease activity were 
consistently associated with no functional dis-
ability.
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